Clinical Trial Update: Rivastigmine For Methamphetamine Dependent Individuals [Phase 1]

View source ↗

Summary

This item reports the completion of a Phase 1 clinical trial evaluating rivastigmine for individuals with methamphetamine dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Substance Use Disorder

Drugs mentioned

• Exelon (rivastigmine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Substance-Related Disorders | Phase 1 | Status: COMPLETED